SiNtx Technologies, Inc. SINT 深 滬
等待開盤 09-09 09:30:00 美东时间
4.59
-0.920
-16.70%
華盛通- 最 高4.80
- 今 開3.95
- 成交量 101.06万股
- 最 低 3.91
- 昨 收 5.51
- 總市值 1264.82万
- 52周最高 8.5961
- 市盈率 靜 --
- 換手率 36.67%
- 52周最低 1.71
- 委 比 77.26%
- 總股本 275.56万
- 歷史最高 209400.00
- 量 比 0.12
- 振 幅 16.15%
- 歷史最低 1.71
- 每 手 1
- 風險率 31.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds
SINTX Technologies, Inc. announced the exercise of warrants to purchase up to 1,099,431 shares of common stock, with an exercise price of $3.32 per share. In exchange, the company will issue new warrants for up to 1,649,147 shares, with an exercise price of $4.79 per share and a 5.5-year term. The offering is expected to raise approximately $3.8 million, to be used for working capital. The new warrants are issued in a private placement under appl...
09-08 11:54
SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent
SINTX Technologies获准一项关于硅氮抗病原体材料的专利，标志着其在感染预防领域的重大进展。该专利将保护硅氮在医疗设备、手术护理、伤口处理、过滤及个人防护设备等领域的应用，预计可显著降低医院感染率，节省医疗成本，并提升患者预后。公司计划通过战略合作和授权协议加速产品商业化，进一步拓展在300亿美元全球感染预防市场的份额。
09-08 11:00
SiNtx Technologies Appoints Kevin Trask As CFO
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001269026/000149315225012731/form8-k.htm
09-06 04:23
Why SINTX Technologies Stock Is Skyrocketing Wednesday
Shares of SINTX Technologies are trading sharply higher Wednesday morning. The stock is gaining following the announcement of a landmark study.
09-04 00:50
SINTX Technologies shares are trading higher after the company announced publication of a study showing silicon nitride demonstrated antiviral activity against multiple virus strains including SARS-CoV-2 and MERS-CoV.
SINTX Technologies shares are trading higher after the company announced public...
09-03 19:26
SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride
SINTX Technologies宣布其硅氮化物在抗病毒研究中取得突破，对SARS-CoV-2和MERS-CoV等病毒表现出强效抑制作用。研究显示，硅氮化物能在10分钟内使病毒滴度减少99.97%，具备广泛应用于医疗纺织品、伤口敷料及HEPA滤网的潜力。作为唯一FDA认证的硅氮化物制造商，SINTX计划通过 Licensing 拓展其技术，目标切入价值2300亿美元的感染控制市场，提供比传统金属抗菌剂更安全高效的选择。
09-03 11:00
SinterCast AB Announces Nomination Committee for 2026 AGM
SinterCast AB ( ($SE:SINT) ) just unveiled an announcement. SinterCast AB has a...
09-01 15:32
Sintercom India Enhances Shareholder Engagement Ahead of AGM
Sintercom India Ltd. ( ($IN:SINTERCOM) ) has issued an update. Sintercom India ...
08-31 01:53
SINTX Provides Business Update Highlighting SiNAPTIC Acquisition and Commercialization Strategy
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing in silicon nitride (Si₃N₄) for medical device applications, today issued a business update in connection with
08-15 19:14
SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition
SINTX Technologies has made significant strides in advancing its commercialization efforts and strategic direction. The company, which specializes in silicon nitride for medical devices, has completed the acquisition of SiNAPTIC Surgical, expanded its leadership team with MedTech experts, and streamlined operations to focus on high-margin opportunities. Over 50,000 spinal devices have been successfully implanted. SINTX has also exited low-margin ...
08-15 11:00
